Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Hum Pathol. 2016 May 14;55:108–116. doi: 10.1016/j.humpath.2016.04.019

Table 1.

Characterization of type I Hodgkin-like lesion and type II CHL-RT

Type I Type II
Number (N) 26 51
Median age in years (range)* 62 (42-86) 73 (46-85)
Gender (M:F ratio) 19:7 (2.7) 31:20 (1.6)
Prior CLL diagnosis# 27% (7/26) 73% (37/51)
Sites (N)# LN 25, BM 1 LN 33, Spleen 4, BM 8, extranodal 6§
CD20+ 52% (12/23) 47% (23/49)
PAX-5+ 100% (20/20) 100% (31/31)
CD30+ 100% (26/26) 100% (51/51)
CD15+ 78% (18/23) 92% (46/50)
EBV+ 65% (17/26) 75% (38/51)
ZAP-70+ 57% (8/14) 32% (6/19)
Clonally related 29% (4/14) 53% (10/19)
*

p=0.01 by student t-test

#

p<0.005 by Fisher exact test,

§

Includes liver (2), lung (2), pleura (1), and stomach (1).